Inari Medical (NARI) News and press releases

Canaccord Genuity Maintains Buy on Inari Medical, Raises Price Target to $80

28 Feb 23

News, Price Target, Analyst Ratings

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and raises the price target from $77 to $80.

Inari Medical Q4 EPS $(0.11) Beats $(0.17) Estimate, Sales $107.77M Beat $104.84M Estimate

27 Feb 23

Earnings, News

Inari Medical (NASDAQ:NARI) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.17) by 35.29 percent. This is a 650 percent decrease over earnings of $0.02 per share from the

Earnings Scheduled For February 27, 2023

27 Feb 23

Earnings

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Inari Medical Earnings Preview

24 Feb 23

Earnings

Analyst Ratings for Inari Medical

21 Feb 23

Analyst Ratings

Canaccord Genuity Maintains Buy on Inari Medical, Raises Price Target to $77

21 Feb 23

News, Price Target, Analyst Ratings

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and raises the price target from $76 to $77.

Analyst Expectations for Inari Medical's Future

31 Jan 23

Analyst Ratings

Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $65

31 Jan 23

News, Price Target, Analyst Ratings

Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and lowers the price target from $75 to $65.

Inari Medical Shares Jump On Better Than Expected Interim Sales For FY22

10 Jan 23

Earnings Misses, Large Cap, News, Health Care, Movers, Trading Ideas, General

Morgan Stanley Maintains Overweight on Inari Medical, Lowers Price Target to $83

6 Jan 23

News, Price Target, Analyst Ratings

Morgan Stanley analyst Cecilia Furlong maintains Inari Medical (NASDAQ:NARI) with a Overweight and lowers the price target from $95 to $83.

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

27 Feb 23

Earnings, Press Releases

IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other

Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

7 Feb 23

News, Press Releases

IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other

Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

31 Jan 23

Press Releases

IRVINE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

12 Jan 23

Press Releases

IRVINE, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari") a medical device company with a mission to treat and transform the lives of patients suffering from venous and other

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

10 Jan 23

Press Releases

IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ:NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other